Ken Fisher Cytokinetics Inc Transaction History
Fisher Asset Management, LLC
- $229 Billion
- Q2 2024
A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Cytokinetics Inc stock. As of the latest transaction made, Fisher Asset Management, LLC holds 534,520 shares of CYTK stock, worth $27.5 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
534,520
Previous 538,797
0.79%
Holding current value
$27.5 Million
Previous $37.8 Million
23.34%
% of portfolio
0.01%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding CYTK
# of Institutions
407Shares Held
126MCall Options Held
3.29MPut Options Held
2.01M-
Black Rock Inc. New York, NY14.7MShares$755 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.4MShares$589 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD8.14MShares$419 Million0.28% of portfolio
-
Wellington Management Group LLP Boston, MA7.51MShares$387 Million0.07% of portfolio
-
State Street Corp Boston, MA6.55MShares$337 Million0.02% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.85B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...